期刊文献+

统计参数图在Alzheimer病PET成像中的应用

Application of statistical parametric mapping in Alzheimer's disease positron emission tomography imaging
下载PDF
导出
摘要 研究统计参数图(SPM)分析方法在Alzheimer病(AD)PET成像中的作用。方法:利用F-FDGPET成像方法分别对11例AD及12例对照者进行PET脑显像,采用SPM方法进行分析,总结AD的成像特点。结果:SPM分析方法显示,AD患者两侧大脑皮层顶叶、颞叶、额叶及后扣带回等部位葡萄糖代谢明显降低,左、右不对称。而两侧皮层下基底节区等结构代谢不受影响。结论:SPM方法能够客观准确显示出AD患者脑代谢降低部位,为康复治疗的脑功能研究提供一种实用的工具。 Objective:To investigate the role of statistical parametric mapping method in Alzheimer' s disease PET imaging.Method:11AD patients and12controls were studied with brain PET and the data were analyzed using SPM.The characteristics of AD PET imaging were summarized.Result:SPM results showed that cerebral metabolic rate of glucose decreased in parietal lobe,temporal lobe,frontal lobe and post cingulate bilaterally in AD patients,and right/left hemispheric asymmetry was found.The hypometablism was spared in basal ganglia and other regions.Conclusion:SPM method can show hypometablism area in AD patients objectively and accurately,which offers a practical tool in investigating brain function of rehabilitative treatment.
出处 《中国康复医学杂志》 CAS CSCD 2003年第12期728-730,共3页 Chinese Journal of Rehabilitation Medicine
关键词 统计参数图 ALZHEIMER病 PET成像 脑功能 SPM方法 认知障碍 statistical parametric mapping Alzheimer's disease positron emission tomography
  • 相关文献

参考文献9

  • 1[1]Silverman DHS, Small GW, Phelps ME. Clinical value of neu roimaging in the diagnosis of dementia:sensitivity and specificity of regional cerebral metabolic and other parameters for early i dentification of Alzheimer′s disease[J]. Clinical Positron Imaging, 1999, 2(3):119-130.
  • 2[2]Morgan AE, Brodie JD, Dewey SL.What are we measuring withPET[J]? Q J Nucl Med, 1998, 42:151-157.
  • 3[3]Kathleen C, Schmidt, Giovanni L, et al. Fluorine-18-Fluorodeoxyglucose PET to determine regional cerebral glucose uti lization:A re-examination[J]. J Nucl Med, 1996,37:394-399.
  • 4[4]Signorini M, Paulesu E, Friston K, et al. Rapid assessment of regional cerebral metabolicabnormalities in single subject with quantitative and nonquantitative [18F]FDG PET: a clinicalvalidation of statistical parametric mapping[J]. Neuroimage,1999, 9:63-80.
  • 5[5]Acton PD, Friston KJ. Statistical parametric mapping in func tional neuroimaing: beyond PET and fMRI activation studies[J]. Eur J Nucl Med,1998, 25:663-667.
  • 6[6]Staff RT,Venneri A, Gemmell HG,et al. HMPAO SPECT imag ing of Alzheimer′s disease patients with similar content-specific autobiographic delusion: comparison using statistical parametric mapping[J]. J Nucl Med,2000,41(9):1451-1455.
  • 7[7]Friston K J, Holmes AP, Worsley KJ, et al. Statistical paramet ric mapping: ageneral linear approach [J]. Hum Brain Mapp, 1995,2:189-210.
  • 8[8]Nagata K, Maruya H, Yuya H, et al. Can PET data differenti ate Alzheimer′s disease from vascular dementia [J]? Ann N Y Acad Sci, 2000, 903:252-261.
  • 9[9]Jelic V, Nordberg A. Early diagnosis of Alzheimer disease with positron emission tomography [J]. Alzheimer Dis Assoc Disord, 2000,14(Suppl 1):S109-113.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部